|
妊娠合并HELLP综合征的临床研究进展
|
Abstract:
HELLP综合征(hemolysis, elevated liver enzymes, and low platelet count syndrome, HELLP syn-drome)是子痫前期的严重阶段,主要表现为溶血、肝酶升高和血小板减少,可引起多脏器功能障碍,对母婴危害极大,是孕产妇和围产期发病率和死亡率的重要原因之一。尽管国内外对于HELLP综合征的认识在不断加深,但其发病机制尚未完全明确,且临床表现往往呈现非典型、临床多样化,病情发展快,容易误诊、漏诊。使用糖皮质激素、补充血制品及适时终止妊娠是治疗HELLP综合征的重要方法。本文就其发病机制、临床表现、诊断标准、鉴别诊断、治疗方案等方面作一综述,便于在临床工作中引起重视、及早处理、改善预后。
HELLP syndrome is a severe stage of preeclampsia, mainly characterized by hemolysis, elevated liver enzymes and thrombocytopenia, which can cause multiple organ dysfunction and great harm to maternal and infant, and is one of the important causes of maternal and perinatal morbidity and mortality. Despite the deepening understanding of HELLP syndrome at home and abroad, the pathogenesis of HELLP syndrome is not completely clear, and its clinical manifestations are often atypical and clinical diversification, with rapid disease development and easy misdiagnosis and missed diagnosis. The use of glucocorticoids, blood supplement and timely termination of pregnan-cy are important methods for the treatment of HELLP syndrome. In this paper, the pathogenesis, clinical manifestations, diagnostic criteria, differential diagnosis and treatment are reviewed in or-der to improve the prognosis and arouse attention in clinical work.
[1] | Weinstein, L. (1982) Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count: A Severe Consequence of Hypertension in Pregnancy. American Journal of Obstetrics & Gynecology, 142, 159-167.
https://doi.org/10.1016/S0002-9378(16)32330-4 |
[2] | Sitaula, S., Manandhar, T., Thapa, B.-D., Shrestha, R. and Dharel, D. (2020) Prevalence of Hemolysis, Elevated Liver Enzymes, Low Platelet Count Syndrome in Pregnant Women in a Tertiary Care Hospital. Journal of Nepal Medical Association, 58, 405-408. https://doi.org/10.31729/jnma.4921 |
[3] | Dusse, L.-M., Alpoim, P.-N., Silva, J.-T., Rios, D.R. and Brand?o, A.H. and Cabral, A.C. (2015) Revisiting HELLP Syndrome. Clinica Chimica Acta, 451, 117-120. https://doi.org/10.1016/j.cca.2015.10.024 |
[4] | 郑瑞丹. HELLP综合征的临床诊治[J]. 中国临床医生杂志, 2015, 43(2): 6-10. |
[5] | Bu, S, Wang, Y., Sun, S., Zheng, Y., Jin, Z. and Zhi, J. (2018) Role and Mechanism of AT1-AA in the Pathogenesis of HELLP Syndrome. Scientific Reports, 8, Article No. 279. https://doi.org/10.1038/s41598-017-18553-x |
[6] | Morris, R., Spencer, S.-K., Kyle, P.-B., Williams, J.M., Harris, A., Owens, M.Y., et al. (2016) Hypertension in an Animal Model of HELLP Syndrome Is Associated with Activation of Endothelin. Reproductive Sciences, 23, 42-50.
https://doi.org/10.1177/1933719115592707 |
[7] | Yang, X., Guo, L., Li, H., Chen, X. and Tong, X. (2012) Analy-sis of the Original Causes of Placental Oxidative Stress in Normal Pregnancy and Pre-Eclampsia: A Hypothesis. The Journal of Maternal-Fetal & Neonatal Medicine, 25, 884-888. https://doi.org/10.3109/14767058.2011.601367 |
[8] | 李嘉健, 孙晓燕. 氧化应激作用在子痫前期发病机制中的研究进展[J]. 疑难病杂志, 2020, 19(4): 417-422. |
[9] | Chen, S., Li, Z., He, Y. and Chen, Q. (2021) Dysregulation of Complement System in HELLP Syndrome. Hypertension in Pregnancy, 40, 303-311. https://doi.org/10.1080/10641955.2021.1983593 |
[10] | Burwick, R.-M. and Feinberg, B.-B. (2013) Eculizumab for the Treatment of Preeclampsia/HELLP Syndrome. Placenta, 34, 201-203. https://doi.org/10.1016/j.placenta.2012.11.014 |
[11] | 于欢, 杨孜, 丁晓燕, 王伽略, 王雁玲, 韩怡炜. 子痫前期HELLP和APS血清游离脂肪酸水平对滋养细胞脂质沉积影响的研究[J]. 中国妇产科临床杂志, 2014, 15(5): 422-425. |
[12] | Sandvo?, M., Potthast, A.-B., von Versen-H?ynck, F. and Das, A.M. (2017) HELLP Syndrome: Altered Hypoxic Response of the Fatty Acid Oxidation Regulator SIRT 4. Reproductive Sciences, 24, 568-574.
https://doi.org/10.1177/1933719116667216 |
[13] | Petca, A., Miron, B.-C., Pacu, I., Dumitra?cu, M.C., Mehedin?u, C., ?andru, F., et al. (2022) HELLP Syndrome-Holistic Insight into Pathophysiology. Medicina (Kaunas), 58, Article No. 326. https://doi.org/10.3390/medicina58020326 |
[14] | Dryllis, G., Liakou, P. and Politou, M. (2020) Genetic Polymorphisms Implicated in Major Pregnancy Complications: A Review. Folia Medica, 62, 230-237. https://doi.org/10.3897/folmed.62.e47831 |
[15] | Arigita, L.-M. and Martinez, F.-G.S. (2020) HELLP Syndrome: Controversies and Prognosis. Hipertensión y Riesgo Vascular, 37, 147-151. https://doi.org/10.1016/j.hipert.2020.07.002 |
[16] | Rimaitis, K., Grauslyte, L., Zavackiene, A., Baliuliene, V., Nad-isauskiene, R. and Macas, A. (2019) Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre. In-ternational Journal of Environmental Research and Public Health, 16, Article No. 109. https://doi.org/10.3390/ijerph16010109 |
[17] | Yoshida, Y., Matsumoto, M., Yagi, H., Isonishi, A., Sakai, K., et al. (2017) Severe Reduction of Free-Form ADAMTS13, Unbound to Von Willebrand Factor, in Plasma of Patients with HELLP Syndrome. Blood Advances, 1, 1628-1631.
https://doi.org/10.1182/bloodadvances.2017006767 |
[18] | De Villiers, C.-P., Hedley, P.-L., Placing, S., W?jde-mann, K.R., Shalmi, A.C., Carlsen, A.L., et al. (2017) Placental Protein-13 (PP13) in Combination with PAPP-A and Free Leptin Index (fLI) in First Trimester Maternal Serum Screening for Severe and Early Preeclampsia. Clinical Chem-istry and Laboratory Medicine, 56, 65-74.
https://doi.org/10.1515/cclm-2017-0356 |
[19] | 王美蓉, 徐琳, 高林. APRI评分对HELLP综合征预测价值[J]. 青岛大学学报(医学版), 2022, 58(2): 193-196. |
[20] | 杨柳, 邹丽. HELLP综合征诊治的最新认识[J]. 中华产科急救电子杂志, 2021, 10(3): 142-146. |
[21] | Nelson, D.-B., Khan, A., Bailey, A., Yokoo, T., Pedrosa, I., McIntire, D.D., et al. (2018) Liver Injury in Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome Measured by Diffu-sion-Weighted Magnetic Resonance Imaging. American Journal of Perinatology, 35, 741-747. https://doi.org/10.1055/s-0037-1613684 |
[22] | Ratiu, D., Hide-Moser, K., Morgenstern, B., Gottschalk, I., Eichler, C., Ludwig, S., et al. (2019) Doppler Indices and Notching Assessment of Uterine Artery Between the 19th and 22nd Week of Pregnancy in the Prediction of Pregnancy Outcome. In Vivo, 33, 2199-2204. https://doi.org/10.21873/invivo.11722 |
[23] | Cetin, O., Karaman, E., Arslan, H., Kolusar?, A., Y?ld?zhan, R., Ozgokce, M., et al. (2017) Evaluation of Maternal Liver Elasticity by Acoustic Radiation Force Impulse Elastosonogra-phy in Hypertensive Disorders of Pregnancy: A Preliminary Descriptive Study. The Journal of Maternal-Fetal & Neo-natal Medicine, 30, 2281-2286.
https://doi.org/10.1080/14767058.2016.1246526 |
[24] | Pecourt, M., Yelnik, C., Ghesquiere, L., Drumez, é., Cailliau, é., Hachulla, é., et al. (2021) Is the Presence of Antiphospholipid Antibodies a Poor Prognostic Factor for Pa-tients with Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome? American Journal of Obstetrics & Gynecology, 225, 431-432.
https://doi.org/10.1016/j.ajog.2021.03.039 |
[25] | Wallace, K., Harris, S., Addison, A. and Bean, C. (2018) HELLP Syndrome: Pathophysiology and Current Therapies. Current Pharmaceutical Biotechnology, 19, 816-826. https://doi.org/10.2174/1389201019666180712115215 |
[26] | Dejene, T.-J., Assefa, D. and Gezahegn, M. (2022) The Effect of Dexamethasone Treatment on the Outcome of Patients with Antepartum HELLP Syndrome: A Prospective Cohort Study. SSRN Electronic Journal.
https://doi.org/10.2139/ssrn.3807319 |
[27] | Takahashi, A., Kita, N., Tanaka, Y., Tsuji, S., One, T., Ishiko, A., et al. (2019) Effects of High-Dose Dexamethasone in Postpartum Women with Class 1 Haemolysis, Elevated Liver Enzymes and Low Platelets (HELLP) Syndrome. Journal of Obstetrics and Gynaecology, 39, 335-339. https://doi.org/10.1080/01443615.2018.1525609 |
[28] | 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志, 2020, 55(4): 227-238. |
[29] | 刘建会. 早发型重度子痫前期并发HELLP综合征终止妊娠时机及对母婴预后的影响[J]. 中国医药指南, 2017, 15(11): 67-68. |
[30] | 康苏娅, 周丽屏, 汪云, 姚仪倩. HELLP综合征期待治疗时间的探讨[J]. 国际妇产科学杂志, 2018, 45(1): 46-50. |
[31] | Cavaignac-Vitalis, M., Vidal, F., Simon-Toulza, C., Boulot, P., Guerby, P., Chantalat, E., et al. (2017) Conservative versus Active Management in HELLP Syndrome: Results from a Cohort Study. The Journal of Mater-nal-Fetal & Neonatal Medicine, 32, 1769-1775. https://doi.org/10.1080/14767058.2017.1416604 |
[32] | Cadoret, F., Guerby, P., Cavaignac-Vitalis, M., Vayssiere, C., Parant, O. and Vidal, F. (2021) Expectant Management in HELLP Syndrome: Predictive Factors of Disease Evolution. The Journal of Maternal-Fetal & Neonatal Medicine, 34, 4029-4034. https://doi.org/10.1080/14767058.2019.1702956 |
[33] | 董红霞. HELLP综合征23例临床分析[J]. 中国医药指南, 2019, 17(12): 143-145. |
[34] | 姬建秀, 陈燕, 白惠, 等. HELLP综合征临床分析[J]. 中国医药, 2019, 14(9): 1390-1393. |
[35] | Erkurt, M.-A., Sarici, A., Kuku, I., Berber, I., Kaya, E., Bicim, S., et al. (2021) The Effect of Therapeutic Plasma Exchange on Management of HELLP Syndrome: The Report of 47 Patients. Transfusion and Apheresis Science, 60, Article ID: 103248. https://doi.org/10.1016/j.transci.2021.103248 |